Revenue: The sum of all revenue fields included for a company's operating activities.
Eli Lilly and Company (LLY) had Revenue of $34.12B for the most recently reported fiscal year, ending 2023-12-31.
Income Statement Financials | |
Revenue |
$34.12B |
$5.24B |
|
$7.08B |
|
$27.04B |
|
$27.67B |
|
$6.46B |
|
$96.70M |
|
$6.55B |
|
$6.55B |
|
$5.24B |
|
$5.24B |
|
$5.24B |
|
$5.24B |
|
$6.46B |
|
$7.99B |
|
900.18M |
|
903.28M |
|
$5.82 |
|
$5.80 |
|
Balance Sheet Financials | |
$25.73B |
|
$12.91B |
|
$38.28B |
|
$64.01B |
|
$27.29B |
|
$18.32B |
|
$25.85B |
|
$53.14B |
|
$10.86B |
|
$-982.60M |
|
$10.86B |
|
949.38M |
|
Cash Flow Statement Financials | |
$4.24B |
|
$-7.15B |
|
$3.50B |
|
$2.07B |
|
$2.82B |
|
$751.60M |
|
$628.50M |
|
$-4.07B |
|
-- |
|
Fundamental Metrics & Ratios | |
0.94 |
|
-- |
|
-- |
|
0.63 |
|
2.32 |
|
79.25% |
|
18.92% |
|
18.92% |
|
23.40% |
|
19.21% |
|
15.36% |
|
$792.50M |
|
-- |
|
-- |
|
-- |
|
0.53 |
|
1.23 |
|
3.01 |
|
121.25 |
|
48.24% |
|
-533.32% |
|
8.19% |
|
17.96% |
|
$11.44 |
|
$0.88 |
|
$4.69 |